New patent for Epizyme Inc drug TAZVERIK

   December 22, 2022    Comments Off on New patent for Epizyme Inc drug TAZVERIK    Posted in: Patent Added

Annual Drug Patent Expirations for TAZVERIK Tazverik is a drug marketed by Epizyme Inc and is included in one NDA. There are twenty-three patents protecting this drug. This drug has…

The post New patent for Epizyme Inc drug TAZVERIK appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog